Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
Open Access
- 1 October 2015
- journal article
- review article
- Published by Medknow in Saudi Journal of Ophthalmology
- Vol. 29 (4) , 287-291
Abstract
Retinochoroidal vascular diseases are the leading causes of blindness in the developed world. They include diabetic retinopathy (DR), retinal vein occlusion, retinopathy of prematurity, age-related macular degeneration (AMD), and pathological myopia, among many others. Several different therapies are currently under consideration for the aforementioned disorders. In the following section, agents targeting platelet-derived growth factor (PDGF) are discussed as a potential therapeutic option for retinochoroidal vascular diseases. PDGF plays an important role in the angiogenesis cascade that is activated in retinochoroidal vascular diseases. The mechanism of action, side effects, efficacy, and the potential synergistic role of these agents in combination with other treatment options is discussed. The future of treatment of retinochoroidal vascular diseases, particularly AMD, has become more exciting due to agents such as PDGF antagonists.Keywords
This publication has 25 references indexed in Scilit:
- Platelet-Derived Growth Factor Over-Expression in Retinal Progenitors Results in Abnormal Retinal Vessel FormationPLOS ONE, 2012
- Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3β phosphorylationJournal of Experimental Medicine, 2010
- Role of PDGF in fibrotic diseases and systemic sclerosisRheumatology, 2008
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor XenograftsCancer Research, 2006
- Insight into the physiological functions of PDGF through genetic studies in miceCytokine & Growth Factor Reviews, 2004
- Photoreceptor-Specific Expression of Platelet-Derived Growth Factor-B Results in Traction Retinal DetachmentThe American Journal of Pathology, 2000
- Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathyExperimental and Clinical Endocrinology & Diabetes, 2000
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factorJournal of Cellular Physiology, 1994